Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Hikal Ltd.

  • NSE: HIKAL

  • BSE: 524735

  • Q
  • V
  • T
  • Expensive Star
58.50/100

Quality Score

High Financial Strength
25.33/100

Valuation Score

Expensive Valuation
75.82/100

Technical Score

Technically Bullish
Broker Average Rating

5.00

Broker Average Rating

MFI

78.79

MFI Overbought

50Day SMA Rs

158.81 Rs

Price above SMA 158.81

Quality score

58.50

High Financial Strength

30Day SMA Rs

169.66 Rs

Price above SMA 169.66

Broker Covering stock

2.00

2 Broker Covering stock

Broker 6M Target upgrade

1.00

1 Broker 6M Target upgrade

Broker 6M Target downgrade

1.00

1 Broker 6M Target downgrade

Momentum score

75.82

Technically Bullish

Price to Book Ratio

2.89

Above industry Median

Broker 1Year total

5.00

5 Broker 1Year total

TTM PE Ratio

31.75

Above industry Median

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

64.41

RSI is mid-range

Net Profit Qtr Cr

15.00 Cr

Above industry Median

AVG Broker Target

-20.18 %

-20.18% downside

Operating Revenues Qtr Cr

352.77 Cr

Above industry Median

MACD

9.06

MACD above Signal and Center

Valuation score

25.33

Expensive Valuation

MACD Signal Line

7.84

MACD above Signal and Center

FII holding %

5.41 %

FII holding increased by 0.55%.

Promoter holding %

68.77 %

No change in Promoter holding

MF holding %

1.26 %

MF holding increased by 0.19%.

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

139.98 Rs

Price above SMA 139.98

Institutions holding %

7.80 %

Institutions holding increased by 0.7%.

AVG Broker Target

152.50 Rs

-20.18% downside

200Day SMA Rs

125.26 Rs

Price above SMA 125.26

NSE HIKAL
191.05
  • 190.85 Close
  • 192.35 Open
  • 13.26 Lk Volume
Today Low/High
Low 188.00
High 195.50
52 Week Low/High
25-03-2020 56.90
30-09-2020 204.55

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Hikal Ltd. 191.05 31.74 2355.64 0.62 15 0 352.77 -12.5 2.88
Sun Pharmaceutical Industries Ltd. 506.9 475.82 121620.51 0.78 -2429.81 0 7585.25 -9.43 2.47
Dr. Reddy's Laboratories Ltd. 5112.05 44.79 84962.27 0.48 586.9 0 4426.5 14.72 5.45
Divi's Laboratories Ltd. 3064.9 50.97 81357.77 0.52 492.06 0 1730.47 48.8 11.12
Cipla Ltd. 773 37.82 62323.12 0.51 571.42 0 4346.16 8.95 3.88
Aurobindo Pharma Ltd. 818.65 15.95 47964.7 0.51 792.68 0 5924.78 8.81 2.85
Torrent Pharmaceuticals Ltd. 2817.2 42.19 47678.29 1.13 321 0 2056 1.68 9.88
Lupin Ltd. 1027.84 -99.66 46571.88 0.58 108.14 0 3527.86 -20.16 3.7